GP和NP方案治疗晚期非小细胞肺癌的疗效观察
在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺,...
Saved in:
Published in | Zhongguo fei ai za zhi Vol. 9; no. 4; pp. 379 - 380 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
Tianjin
Chinese Anti-Cancer Association Chinese Antituberculosis Association
01.07.2006
443000,宜昌市第二人民医院放化疗科 |
Subjects | |
Online Access | Get full text |
ISSN | 1009-3419 1999-6187 |
DOI | 10.3779/cjlc.v9i4.2278 |
Cover
Abstract | 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺, |
---|---|
AbstractList | 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung cancer,NSCLC),其中位生存期仅4~5月,1年生存率为10%~15%。90年代时,随着长春瑞宾、紫杉醇、多西紫杉醇、吉西他滨、伊立替康等新一代抗肿瘤药与铂类联合化疗的应用,将晚期NSCLC患者中位生存期提高到9~10个月,1年生存率提高到30%~50%。我院自2001年1月至2003年12月应用吉西他滨(健泽,gemcitabine)联合顺铂(GP)和长春瑞宾(盖诺, R73 |
Author | 李思维 李拥军 胡远强 蔡正斌 |
AuthorAffiliation | 宜昌市第二人民医院放化疗科,443000 |
AuthorAffiliation_xml | – name: 443000,宜昌市第二人民医院放化疗科 |
Author_xml | – sequence: 1 fullname: 李思维 李拥军 胡远强 蔡正斌 |
BookMark | eNpFz0FLAkEUB_AhDFLr2geoQ6e1mbezMzvdQtICKQ_eZXZ3xjTZTTcLPFqEByEIMpRSOnUsupWfx137Fm0YdPo_eD_-j5dBKT_wFUKbBOdMzsWu22i6uUtRpzkAbq-gNBFCGIzYPJXMGAvDpESsoUwYNjBmIEyaRnvF8vx-cFyOhp_RSz_6mMXDx2g0jp6m38-T-ftdPLtdXE8Wva94NIjHN7_bh_7itTd_m66jVS2bodr4yyyqFA4q-UOjdFI8yu-XDNfmwvA8l4K2OOGYC6k0AcfSJhAMPAmmHErBUppywGA5DsUO4-CB9IhUXElmZtHOsvZK-lr6tWoj6LT95GC1W9Oy24XkF0wxEYncXsrzdtDqqPDinwIBzmwqmJmoraVyTwO_1qonjY50z3S9qaoAFgVOmfkDAw51CQ |
ClassificationCodes | R73 |
ContentType | Journal Article |
Copyright | Copyright © 2006. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © 2006. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA ABUWG AFKRA AZQEC BENPR BVBZV CCPQU DWQXO PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.3779/cjlc.v9i4.2278 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest East & South Asia Database ProQuest One Community College ProQuest Central ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China East & South Asia Database ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1999-6187 |
EndPage | 380 |
ExternalDocumentID | zgfazz200604019 22542746 |
GroupedDBID | --- -05 04C 29R 2B. 2C~ 2RA 2WC 3V. 5GY 5VS 6PF 92F 92I 92L AAWTL ABUWG ACGFS AFKRA ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVBZV C1A CCEZO CDYEO CIEJG CQIGP CW9 CXBCV DIK E3Z EBD EIHBH EMOBN EOJEC F5P GROUPED_DOAJ HYE IPNFZ KQ8 KWQ OBODZ OK1 PIMPY PQEST PQQKQ PQUKI PROAC RIG RNS RPM TCJ TGQ U1G U5O W91 ~WA AZQEC CCPQU DWQXO OVT PGMZT PHGZM PHGZT PKEHL PRINS 4A8 93N PMFND PSX |
ID | FETCH-LOGICAL-c879-ddc42f5717079aef12b5f321027f326eb4425ef472025bb40b672d2ad1ae7ea63 |
IEDL.DBID | BENPR |
ISSN | 1009-3419 |
IngestDate | Thu May 29 03:56:16 EDT 2025 Sun Jun 29 15:35:52 EDT 2025 Thu Nov 24 20:30:11 EST 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | Chinese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c879-ddc42f5717079aef12b5f321027f326eb4425ef472025bb40b672d2ad1ae7ea63 |
Notes | R521 R734.2 12-1395/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://www.proquest.com/docview/2127684963?pq-origsite=%requestingapplication% |
PQID | 2127684963 |
PQPubID | 2055412 |
PageCount | 2 |
ParticipantIDs | wanfang_journals_zgfazz200604019 proquest_journals_2127684963 chongqing_backfile_22542746 |
PublicationCentury | 2000 |
PublicationDate | 20060701 |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 20060701 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Tianjin |
PublicationPlace_xml | – name: Tianjin |
PublicationTitle | Zhongguo fei ai za zhi |
PublicationTitleAlternate | Chinese Journal of Lung Cancer |
PublicationTitle_FL | CHINESE JOURNAL OF LUNG CANCER |
PublicationYear | 2006 |
Publisher | Chinese Anti-Cancer Association Chinese Antituberculosis Association 443000,宜昌市第二人民医院放化疗科 |
Publisher_xml | – name: Chinese Anti-Cancer Association Chinese Antituberculosis Association – name: 443000,宜昌市第二人民医院放化疗科 |
SSID | ssj0062934 ssib002262905 ssib001103766 ssib038074678 ssib044765436 ssib051369142 |
Score | 1.6988766 |
Snippet | 在我国,肺癌已占大城市癌症发病率和死亡率的首位,而且预后极差。20世纪80年代时,用顺铂(cisplatin,DDP)联合丝裂霉素和长春地辛组成标准的化疗方案治疗非小细胞肺癌(non-small cell lung... R73 |
SourceID | wanfang proquest chongqing |
SourceType | Aggregation Database Publisher |
StartPage | 379 |
SubjectTerms | cancer GP NP 中位生存期 多西紫杉醇 方案治疗 晚期非小细胞肺癌 疗效观察 联合化疗 长春瑞宾 |
Title | GP和NP方案治疗晚期非小细胞肺癌的疗效观察 |
URI | http://lib.cqvip.com/qk/91098A/20064/22542746.html https://www.proquest.com/docview/2127684963 https://d.wanfangdata.com.cn/periodical/zgfazz200604019 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PTxNBFJ5oiYaLUZRYQdOD1wVm9u1Ml4tBAxITmsZAwq2ZmZ0tqNmCVEl6BEI4kJiYiIEoxJNHjTfl7-m2_Be8R4cWL5z28Hb28PbN937N-4axp6Gl3lqSBspqGYAJTWBUxIPQgYUw4cAveGYXKnJ-CV4tR8u-4Lbhj1VeYuIFUCcNSzXySWIil2VAe3m2th7QrVHUXfVXaNxkQygvo50PPZ-tVF8PAgIag7uaoAgp4oGFE9s6IkXfAgEUzVr23494KGMOfUIqXNzrU1NLgZjQejSQRNo3ad-8sxMf41WYoOlSompYaWT1dXRA_wWvtzZ1luqsfsWLzd1ld3z4WZrp2cs9dqO1MsJuL_gG-302_bLa_rxfqeYHf_Mfe_mf087B1_zwKP92cvb9uP37U-d0t7t93N361znc7xztkPTLXvfnVvvXyQO2ODe7-GI-8NcrBLas4iBJLIg0wnRuSsXapVyYKKWJHqHwIZ0B3M4uBSUwLDIGpoxUIhE64dopp2U4ygpZI3MPWSkWDiLnXEjk9tYZEyNqlg06f60UB11kY31loHe2b4lzqoZIApgTyyIbv1RPzW-gjdrgdxdZyatsIG3VU91qUTUEMYjHj67_whgb7hVO6JDtOCs0339wjzGUaJon3l7OAXFA0GE |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVDwuiKcILZADHN3W6_FujIQQj5aUNlGEgtSbtbtepzzkUFqoyLEg1EMlJCSKWkErTpwQiBv098QJ_4Kd2knKhVtPPqy9h_G3s9_M7HwLcNXTVFuLYkdoyR1UnnKU8F3HM6jRi1x093VmqzVeeYj3F_yFEfjW74WhY5V9n7jvqKOWphz5JCmR8zJavNx8tuTQrVFUXe1foZHBYs68WrUh2_KN2bv2_15jbGa6cafi5LcKOLosAieKNLLYt1HMlAikiV2m_JgaWZiwD24UWhSbGAWzbEApnFJcsIjJyJVGGMk9O-0RGEVqaC3A6O3pWv3BkH9Q193BeIhxFgwXFIm7W8c0ADyioNbOwfu-6_HAxYH-lf04K4tTBYOE1zLVSdIInNSPn-qJl8EjnKBmVlKGWGwlzSW73_3DlY-uyiSWSfPApjlzCk7mbLd0K4PnaRhpL56BY9W8nn8Wrt-rd95v1Orp5q_0y3r6c6-7-THd2k4_7f75vNP58a6797b3eqe39ru7tdHdfkOjH9Z7X9c633fPQeMw7H4eCkkrMRegFDCDvjHGIy19bZQKrJMuK8s1pBAuyiKMDYxhyYB-QhJXoXVcaENwXoTxvnnCfL0uh0N0FaGUm2w42m7Gst2m5It1eW5w8f8zXIHjlUZ1Ppyfrc2NwYksZ0Pne8ehsPL8hblkWcyKupxjpwThIaP1L8YCDBs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3PT9RAFH7BJRIu_jauoO5Bj92l02mnNTFGxBVENntAQrw0M9PpgpiuyCKxRzSGA4mJiRiIQjx51HhD_hPv213_C-fRdhc9eOPgqYdpm6bfmzffzHvvewDXLYmxtSA0mOSOQYUlDMFs07AUldQKTGoe6szO1JzJR_TBvD0_APt5LQymVeY-8dBRB02JZ-QVVCJ3XKrtpRJmaRH1iertZ8sGdpDCSGveTiM1kWn1ck1v31ZuTU1orG8QUr03e3fSyDoMGNJlnhEEkpLQ1juaMeZxFZpE2CEWtRCmL44SVFu0CikjmhkIQceEw0hAeGByxRR3LP3aEzDoOq5NCjA4Pjf-eK7PRbAC7-jeiDjE608uFHrXTqpn_JQyLPPs3W-bluOZtKeFpR9OQ-QYzUARtlSBEvUCK_LJU1l-4S3SMha2okrEQjNqLOu17w_efHKNRyGPGkcW0Opp-Jn_-jRvZqm82hJlGf-lSvlfYnMGTmW0vnQnnYdnYSBeOAdDM1niwnm4eb_efrdZqydb-8nnjeT7QWfrQ7K9k3zc-_Vpt_3tbefgTffVbnf9R2d7s7PzGkffb3S_rLe_7l2A2eP48ItQiJqRugQljyhqK6UsbBoglRCeXo1coUkVZ8ykvAgjPaQ165FLqOXlaw9NibatIozmaPmZY1rx-1AVoZTZQ380boQ8jvGUSft207v87zdcgyENs_9wqjY9AsPp2RTmMY9CofV8VV3RbK0lrmbzogT-MaP9Gx5KV1o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GP%E5%92%8CNP%E6%96%B9%E6%A1%88%E6%B2%BB%E7%96%97%E6%99%9A%E6%9C%9F%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C%E7%9A%84%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E6%9D%8E%E6%80%9D%E7%BB%B4&rft.au=%E6%9D%8E%E6%8B%A5%E5%86%9B&rft.au=%E8%83%A1%E8%BF%9C%E5%BC%BA&rft.au=%E8%94%A1%E6%AD%A3%E6%96%8C&rft.date=2006-07-01&rft.pub=443000%2C%E5%AE%9C%E6%98%8C%E5%B8%82%E7%AC%AC%E4%BA%8C%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E6%94%BE%E5%8C%96%E7%96%97%E7%A7%91&rft.issn=1009-3419&rft.volume=9&rft.issue=4&rft.spage=379&rft.epage=380&rft_id=info:doi/10.3779%2Fcjlc.v9i4.2278&rft.externalDocID=zgfazz200604019 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg |